Listen: Can California Lower the Price of Insulin?
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
The independent source for health policy research, polling, and news.
81-100 of 155 results
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
The failure of single-payer health care legislation in California casts doubt on the ability of other states to pass government-run, universal health care. But activists in New York, Washington state, and elsewhere say they are taking lessons from California and changing their tactics.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Whether a simple operation is performed under the auspices of a hospital or at an independent surgery center can make a huge difference in cost.
Anti-vaccination activists say California’s Democratic lawmakers are helping strengthen their movement nationally by pushing for tougher vaccine requirements — without exemptions for religious or personal beliefs. But a new pro-vaccine lobbying force is vowing to fight back.
California has embarked on an ambitious five-year initiative to improve the health of its sickest Medicaid patients by introducing nontraditional services. In the Inland Empire, where many residents have diabetes, one health plan is diving into the experiment by delivering healthy, prepared meals to those lucky enough to get them.
In January, California’s Medicaid program will begin offering nontraditional services —such as ridding homes of roaches, replacing mattresses and installing air purifiers — to some low-income asthma patients. But the rollout could be chaotic, with insurance companies struggling to identify groups that can deliver the services.
The Supreme Court’s decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Angela Hart, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about two identical eye surgeries with very different price tags.
A federal judge in Texas has dealt a big setback to the Affordable Care Act. The same judge who tried in 2018 to declare the entire ACA unconstitutional has now ruled that the law’s main provisions for preventive care are unconstitutional and, therefore, unenforceable nationwide. Also this week, North Carolina became the 40th state to expand Medicaid under the ACA. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sandhya Raman of CQ Roll Call join KHN chief Washington correspondent Julie Rovner to discuss these issues and more.
If Gov. Gavin Newsom survives Tuesday’s recall election, the health care unions that have campaigned on his behalf intend to pressure him to follow through on his promise to establish a government-run health system in California.
Gov. Gavin Newsom has launched several initiatives to cut rising drug prices, but the savings haven’t been as monumental as he promised. And his plan to have California make its own generic drugs hasn’t gotten off the ground.
California is embarking on a five-year experiment to infuse its health insurance program for low-income people with billions of dollars in nonmedical services spanning housing, food delivery and addiction care. Gov. Gavin Newsom said the goal is to improve care for the program’s sickest and costliest members and save money, but will it work?
Democratic Gov. Gavin Newsom’s pandemic policies are effectively on California’s Sept. 14 recall ballot — and the electorate views them with a mix of resentment, gratitude and disillusionment.
The backroom deal with politically connected Kaiser Permanente, which infuriated other Medi-Cal health plans, allows the health care giant to continue selecting the enrollees it wants.
Gov. Gavin Newsom wants to regulate out-of-control health care spending in California. The effort is being shaped by the very health industry players that would be regulated.
On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.
After years of unstable funding, California’s 2022-23 budget will include a dramatic new investment in public health. Insiders say a powerhouse lobbying campaign made all the difference.
California’s vaccination rates have stagnated, particularly in Black and Latino inner-city neighborhoods and in rural towns. County health officials, who say trust is their most important commodity, need more money for one-on-one interactions with holdouts, but the state has instead largely funneled money to advertising firms and tech companies.
California Democratic lawmakers are asking Gov. Gavin Newsom to approve $100 million per year to fund programs that address health inequality and structural racism.
KHN’s Angela Hart leads a lively discussion on the challenges facing California’s mental health care system and potential solutions. The panel was part of a broader symposium on mental health and addiction hosted by the Sacramento-based publication Capitol Weekly.
© 2026 KFF